Hazzazi Mohammad A, Rashaed Saba Al
Vitreoretina Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Department of Vitreoretina, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Middle East Afr J Ophthalmol. 2020 Jan 29;26(4):223-228. doi: 10.4103/meajo.MEAJO_162_19. eCollection 2019 Oct-Dec.
The aim of this study is to evaluate the determinants of visual outcomes, complications after managing the posterior dislocated intraocular lens (IOL).
Patients with posterior dislocated IOL managed between 2002 and 2016 in our institute were reviewed. Ocular status and causes for dislocation were noted. Success was defined as uncorrected visual acuity (UCVA) of 20/20-20/200 at the last follow-up. The risk factors were associated with the success.
Of the 79 eyes with posterior dislocated IOL, 40 (50.6%) eyes had vision <20/400 at presentation. Glaucoma and retinal detachment were present in 12 (15.2%) and 5 (6.3%) eyes. IOL was removed from 33 (41.8%) eyes. Secondary IOL was implanted in 25 (31.6%) eyes, and IOL was repositioned in 19 (24.1%) eyes. The median duration of follow-up was 2.1 years. The final UCVA was "20/20-20/60" and ">20/200" in 45 (57%) and 14 (17.7%) eyes. The main causes of Severe visual impairment (SVI) included glaucoma (5), corneal decompensation (5), retinal detachment (4), and macular edema (3). Young age ( = 0.02), late IOL dislocation ( = 0.005), primary IOL implant ( < 0.01), SVI ( = 0.09), IOL removal ( = 0.06), and no glaucoma at presentation were significantly associated to the success. Late IOL dislocation ( = 0.05) and no glaucoma ( = 0.05) were independently associated to the success.
The management of the dislocation of IOL had promising visual outcomes. Glaucoma and early dislocation predict poor vision after dislocated IOL management. Close monitoring is needed to manage complications.
本研究旨在评估后脱位人工晶状体(IOL)处理后的视觉预后决定因素及并发症。
回顾2002年至2016年在我院接受后脱位IOL处理的患者。记录眼部状况及脱位原因。成功定义为最后一次随访时未矫正视力(UCVA)达到20/20 - 20/200。分析与成功相关的危险因素。
79只后脱位IOL眼中,40只(50.6%)眼初诊时视力<20/400。12只(15.2%)眼存在青光眼,5只(6.3%)眼存在视网膜脱离。33只(41.8%)眼的IOL被取出。25只(31.6%)眼植入了二期IOL,19只(24.1%)眼的IOL被重新定位。中位随访时间为2.1年。45只(57%)眼的最终UCVA为“20/20 - 20/60”,14只(17.7%)眼的最终UCVA为“>20/200”。严重视力损害(SVI)的主要原因包括青光眼(5例)、角膜失代偿(5例)、视网膜脱离(4例)和黄斑水肿(3例)。年轻(P = 0.02)、IOL脱位较晚(P = 0.005)、一期IOL植入(P < 0.01)、SVI(P = 0.09)、IOL取出(P =